AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10091913 — intervention group
Group type: COMPARATOR
Intervention: Latin square design
Number of subjects: 0
Study 8748429 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of nefazodone (NEF) twice daily
Number of subjects: 48
Study 8748429 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of lorazepam (LOR) twice daily
Number of subjects: 48
Study 8748429 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2 mg of LOR and 200 mg of NEF (LOR+NEF) twice daily
Number of subjects: 48
Study 8748429 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) twice daily
Number of subjects: 48
Study 1681162 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan 100 mg
Number of subjects: 61
Study 1681162 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study 6626477 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to 100 ppm of toluene for 6.5 hours
Number of subjects: 75
Study 6626477 — intervention group
Group type: COMPARATOR
Intervention: Exposure to 0 ppm of toluene for 6.5 hours
Number of subjects: 75
Study 6626477 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic exposure to toluene vapour at concentrations of about 100 ppm for 17 years
Number of subjects: 75
Study 31472160 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy eyes
Number of subjects: 80
Study 31472160 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 80
Study 31238161 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept therapy (weekly or every other week administration)
Number of subjects: 22
Study 31238161 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept therapy
Number of subjects: 22
Study 31238161 — intervention group
Group type: COMPARATOR
Intervention: Abatacept therapy (every 4 weeks)
Number of subjects: 22
Study 29025270 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored colorectal cancer screening decision aid including a values clarification exercise and individualized decision-making worksheet
Number of subjects: 424
Study 29025270 — intervention group
Group type: COMPARATOR
Intervention: Attention control group receiving an educational pamphlet on safe driving behaviors
Number of subjects: 424
Study 27307704 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 3-monthly injections (PP-3M)
Number of subjects: 0
Study 27307704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25157899 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-ended comprehension assessment
Number of subjects: 0
Study 25157899 — intervention group
Group type: COMPARATOR
Intervention: Open-ended comprehension assessment
Number of subjects: 0
Study 25157899 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived ease of comprehension
Number of subjects: 0
Study 23069273 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagally mediated heart rate variability (HRV) measured using HF-power (ms(2))
Number of subjects: 36
Study 23069273 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic-related distress
Number of subjects: 36
Study 23069273 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of panic disorder (PD)
Number of subjects: 36
Study 19648684 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthosis combined with walker
Number of subjects: 126
Study 19648684 — intervention group
Group type: COMPARATOR
Intervention: Improved hip frog cast fixation
Number of subjects: 126
Study 17560664 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen + diphenhydramine + pseudoephedrine (Group-1)
Number of subjects: 148
Study 17560664 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen only (Group-2)
Number of subjects: 148
Study 15120369 — intervention group
Group type: EXPERIMENTAL
Intervention: Division of all short gastric vessels
Number of subjects: 99
Study 15120369 — intervention group
Group type: COMPARATOR
Intervention: Intact short gastric vessels
Number of subjects: 99
Study 11597378 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pilocarpine (OP)
Number of subjects: 32
Study 11597378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9855155 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.25% verapamil (single drop)
Number of subjects: 20
Study 9855155 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.25% verapamil (2-week administration)
Number of subjects: 20
Study 9855155 — intervention group
Group type: COMPARATOR
Intervention: Placebo (single drop)
Number of subjects: 20
Study 9855155 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2-week administration)
Number of subjects: 20
Study 8028387 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 40
Study 8028387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2925973 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral marital therapy (BMT)
Number of subjects: 79
Study 2925973 — intervention group
Group type: EXPERIMENTAL
Intervention: Insight-oriented marital therapy (IOMT)
Number of subjects: 79
Study 2925973 — intervention group
Group type: COMPARATOR
Intervention: Treatment-on-demand (TOD) waiting-list control group
Number of subjects: 79
Study 31654154 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective photobiomodulation session applied at the main respiratory muscles using a cluster with 69 LEDs (35 red at 630±10 nm, 10 mW, 0.2 cm²; 34 near-infrared at 830±20 nm, 10 mW, 0.2 cm²)
Number of subjects: 12
Study 31654154 — intervention group
Group type: COMPARATOR
Intervention: Sham photobiomodulation session (no light emitted)
Number of subjects: 12
Study 31206975 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV ± O2
Number of subjects: 29
Study 31206975 — intervention group
Group type: COMPARATOR
Intervention: LFO2
Number of subjects: 29
Study 29073592 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol
Number of subjects: 240
Study 29073592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 25963445 — intervention group
Group type: EXPERIMENTAL
Intervention: CEPIDEA School-Based Program
Number of subjects: 291
Study 25963445 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 291
Study 23764394 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercises (10-minute duration after working hours for 3 months)
Number of subjects: 134
Study 21527660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 337
Study 21527660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study 18321745 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 0.01% raspberry ketone (RK)
Number of subjects: 10
Study 16236532 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetic flush (bupivacaine 0.25% + adrenaline)
Number of subjects: 100
Study 16236532 — intervention group
Group type: COMPARATOR
Intervention: Saline control flush
Number of subjects: 100
Study 14522625 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% licorice topical gel
Number of subjects: 60
Study 14522625 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% licorice topical gel
Number of subjects: 60
Study 14522625 — intervention group
Group type: COMPARATOR
Intervention: Base gel (control)
Number of subjects: 60
Study 10903010 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil-point needle (Pencan, B. Braun)
Number of subjects: 313
Study 10903010 — intervention group
Group type: COMPARATOR
Intervention: Quincke needle (Spinocan, B. Braun)
Number of subjects: 313
Study 10903010 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of pencil-point needle
Number of subjects: 313
Study 8981141 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser zona opening (PALM UV Laser microbeam) applied on embryos from group A (216 laser-treated and 223 not treated)
Number of subjects: 407
Study 8981141 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser zona opening (PALM UV Laser microbeam) applied on embryos from group B (218 laser-treated embryos only)
Number of subjects: 407
Study 8981141 — intervention group
Group type: COMPARATOR
Intervention: Control group (98 patients, embryos not laser treated)
Number of subjects: 407
Study 1599063 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine (Scopoderm TTS CIBA)
Number of subjects: 67
Study 1599063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 3910832 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer based education (CBE)
Number of subjects: 0
Study 31438863 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Resistance Training (CRT) 3 home sessions/week for 10 weeks
Number of subjects: 120
Study 31438863 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad-libitum plant-based Mediterranean diet (limited consumption of eggs, dairy, and fish; avoidance of red meat and poultry)
Number of subjects: 120
Study 31438863 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/day
Number of subjects: 120
Study 31438863 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT added to empagliflozin and diet arms for an additional 10 weeks
Number of subjects: 120
Study 30517579 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and motivational video intervention for controlling liquid intake.
Number of subjects: 192
Study 30517579 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no specific intervention mentioned).
Number of subjects: 192
Study 27799756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectoin® inhalation solution
Number of subjects: 0
Study 27799756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24612637 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Collaboratives (QICs) participation
Number of subjects: 32
Study 22340923 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient education program
Number of subjects: 528
Study 22340923 — intervention group
Group type: COMPARATOR
Intervention: Historical cohort (control)
Number of subjects: 528
Study 20035240 — intervention group
Group type: EXPERIMENTAL
Intervention: Histone deacetylase inhibitor vorinostat
Number of subjects: 0
Study 20035240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17038533 — intervention group
Group type: EXPERIMENTAL
Intervention: RIC-HSCT
Number of subjects: 99
Study 15823183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone administered twice daily
Number of subjects: 1517
Study 15823183 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone administered once daily
Number of subjects: 1517
Study 11956267 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy with Melacine vaccine
Number of subjects: 689
Study 11956267 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 689
Study 11956267 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant therapy with Melacine vaccine among HLA-A2-positive and/or HLA-C3-positive patients
Number of subjects: 689
Study 11956267 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group) among HLA-A2-positive and/or HLA-C3-positive patients
Number of subjects: 689
Study 9652612 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 63
Study 9652612 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 63
Study 7647348 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation instruction (approximately 2 minutes)
Number of subjects: 426
Study 2748714 — intervention group
Group type: EXPERIMENTAL
Intervention: triazolam 0.5 mg
Number of subjects: 120
Study 2748714 — intervention group
Group type: EXPERIMENTAL
Intervention: lormetazepam 2 mg
Number of subjects: 120
Study 2748714 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study 322821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g amoxycillin plus 1 g probenecid
Number of subjects: 104
Study 322821 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g amoxycillin plus 1 g probenecid
Number of subjects: 104
Study 322821 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 104
Study 322821 — intervention group
Group type: COMPARATOR
Intervention: Sensitivity of Neisseria gonorrhoeae to amoxycillin
Number of subjects: 104
Study 31254678 — intervention group
Group type: EXPERIMENTAL
Intervention: Time2bHealthy online program for parents
Number of subjects: 0
Study 31254678 — intervention group
Group type: COMPARATOR
Intervention: Emailed links to information from an evidence-based parenting website
Number of subjects: 0
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete resection (95-100%)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross total resection (90-95%)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete resection (50-90%)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsy (<50%)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: Image Defined Risk Factors (IDRF)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: MYCN (non-amplified)
Number of subjects: 179
Study 28778185 — intervention group
Group type: EXPERIMENTAL
Intervention: MYCN (amplified)
Number of subjects: 179
Study 26999837 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic steroid + intratympanic steroid as supplementary treatment (group A)
Number of subjects: 68
Study 26999837 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial intratympanic steroid (group B)
Number of subjects: 68
Study 26999837 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic steroid as supplementary treatment (12 patients in group A)
Number of subjects: 68
Study 24280743 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg bid)
Number of subjects: 24
Study 24280743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21679264 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day)
Number of subjects: 43
Study 21679264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 19500127 — intervention group
Group type: EXPERIMENTAL
Intervention: Mohs micrographic surgery (MMS) with 2-mm margins
Number of subjects: 30
Study 19500127 — intervention group
Group type: COMPARATOR
Intervention: Standard surgery with 4-mm margins
Number of subjects: 30
Study 16679259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine 2D
Number of subjects: 41
Study 16679259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine TDI
Number of subjects: 41
Study 16679259 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine SRI
Number of subjects: 41
Study 16679259 — intervention group
Group type: EXPERIMENTAL
Intervention: Tl SPECT
Number of subjects: 41
Study 16679259 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined SRI indexes with Tl SPECT
Number of subjects: 41
Study 15151263 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH therapy (0.25 IU/kg subcutaneously 3x/week after each dialysis session)
Number of subjects: 19
Study 11125344 — intervention group
Group type: EXPERIMENTAL
Intervention: New cleanser (soaked dentures)
Number of subjects: 35
Study 11125344 — intervention group
Group type: COMPARATOR
Intervention: Water (soaked dentures)
Number of subjects: 35
Study 9294877 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (18.75 g creatine monohydrate daily for 5 days prior to and 2.25 g creatine daily during testing)
Number of subjects: 18
Study 9294877 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5 g of calcium chloride daily for 5 days prior to the first set of work bouts)
Number of subjects: 18
Study 8346000 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 14
Study 8346000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 3579012 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 ppm ozone exposure
Number of subjects: 8
Study 28942683 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate fixation
Number of subjects: 16
Study 28942683 — intervention group
Group type: COMPARATOR
Intervention: Compression screw fixation
Number of subjects: 16
Study 29550238 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP) with 'rescue' CPAP backup
Number of subjects: 435
Study 29550238 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP) without 'rescue' CPAP backup
Number of subjects: 435
Study 29550238 — intervention group
Group type: COMPARATOR
Intervention: High-flow therapy with 'rescue' CPAP backup
Number of subjects: 435
Study 29550238 — intervention group
Group type: COMPARATOR
Intervention: High-flow therapy without 'rescue' CPAP backup
Number of subjects: 435
Study 27425415 — intervention group
Group type: EXPERIMENTAL
Intervention: Active SPG acupuncture (AA group)
Number of subjects: 39
Study 27425415 — intervention group
Group type: COMPARATOR
Intervention: Sham SPG acupuncture (SA group)
Number of subjects: 39
Study 24004556 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 15
Study 24004556 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with Mediterranean Diet (MD)
Number of subjects: 15
Study 23662515 — intervention group
Group type: EXPERIMENTAL
Intervention: Unbalanced solutions in infusion therapy
Number of subjects: 54
Study 23662515 — intervention group
Group type: COMPARATOR
Intervention: Balanced solutions in infusion therapy
Number of subjects: 54
Study 20230331 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 5mg tablets daily for 4 weeks
Number of subjects: 46
Study 20230331 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 46
Study 17652268 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive educational intervention
Number of subjects: 24
Study 17652268 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline barrier assessment using qualitative and quantitative techniques
Number of subjects: 24
Study 16133949 — intervention group
Group type: EXPERIMENTAL
Intervention: Juror orientation videotape
Number of subjects: 0
Study 16133949 — intervention group
Group type: COMPARATOR
Intervention: Not exposed to the orientation videotape (Control)
Number of subjects: 0
Study 12138953 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) for 14 weeks
Number of subjects: 29
Study 12138953 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo) for 14 weeks
Number of subjects: 29
Study 10444703 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral ischemic lesions of the frontal eye field
Number of subjects: 6
Study 10444703 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral ischemic lesions of the dorsolateral prefrontal cortex
Number of subjects: 6
Study 10444703 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined lesions of the frontal eye field and dorsolateral prefrontal cortex
Number of subjects: 6
Study 8679292 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 in alum at 0, 1, and 6 months (group A)
Number of subjects: 25
Study 8679292 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 at 0 and 1 months followed by V3 at 3 and 6 months formulated in alum (group B)
Number of subjects: 25
Study 8679292 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160 at 0 and 1 months followed by V3 at 3 and 6 months formulated in Freund's incomplete adjuvant (FIA) (group C)
Number of subjects: 25
Study 8679292 — intervention group
Group type: EXPERIMENTAL
Intervention: rgp160
Number of subjects: 25
Study 8679292 — intervention group
Group type: EXPERIMENTAL
Intervention: V3 peptide
Number of subjects: 25
Study 2143104 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin (75 to 1,000 mg)
Number of subjects: 96
Study 2143104 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin (600 mg and above)
Number of subjects: 96
Study 2143104 — intervention group
Group type: EXPERIMENTAL
Intervention: Trospectomycin (1,000 mg)
Number of subjects: 96
Study 2143104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 841605 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation under 95% O2 plus 5% CO2 inhalation
Number of subjects: 0
Study 841605 — intervention group
Group type: EXPERIMENTAL
Intervention: Uneven fractionation irradiation
Number of subjects: 0
Study 841605 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative irradiation
Number of subjects: 0
Study 841605 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 0
Study 30958319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation over the contralesional cerebellar hemisphere + cathodal transcutaneous spinal direct current stimulation in combination with robotic training
Number of subjects: 40
Study 30958319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation over the ipsilesional cerebellar hemisphere + cathodal transcutaneous spinal direct current stimulation in combination with robotic training
Number of subjects: 40
Study 27878566 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster-acting insulin aspart (faster aspart)
Number of subjects: 46
Study 27878566 — intervention group
Group type: COMPARATOR
Intervention: Insulin aspart
Number of subjects: 46
Study 25877495 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (folic acid 0.8 mg, vitamin B-6 20 mg, vitamin B-12 0.5 mg)
Number of subjects: 168
Study 25877495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 24032554 — intervention group
Group type: EXPERIMENTAL
Intervention: ixekizumab 10, 25, 75 or 150 mg subcutaneously
Number of subjects: 114
Study 21679091 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB)
Number of subjects: 0
Study 19538811 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1000 mg Ca)
Number of subjects: 12
Study 19538811 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate (1000 mg Ca)
Number of subjects: 12